These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 22592800)

  • 1. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.
    Busche MA; Chen X; Henning HA; Reichwald J; Staufenbiel M; Sakmann B; Konnerth A
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8740-5. PubMed ID: 22592800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-amyloid monomer scavenging by an anticalin protein prevents neuronal hyperactivity in mouse models of Alzheimer's Disease.
    Zott B; Nästle L; Grienberger C; Unger F; Knauer MM; Wolf C; Keskin-Dargin A; Feuerbach A; Busche MA; Skerra A; Konnerth A
    Nat Commun; 2024 Jul; 15(1):5819. PubMed ID: 38987287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.
    Wright AL; Zinn R; Hohensinn B; Konen LM; Beynon SB; Tan RP; Clark IA; Abdipranoto A; Vissel B
    PLoS One; 2013; 8(4):e59586. PubMed ID: 23560052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.
    Yao J; Sun B; Institoris A; Zhan X; Guo W; Song Z; Liu Y; Hiess F; Boyce AKJ; Ni M; Wang R; Ter Keurs H; Back TG; Fill M; Thompson RJ; Turner RW; Gordon GR; Chen SRW
    Cell Rep; 2020 Sep; 32(12):108169. PubMed ID: 32966798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vicious cycle of β amyloid-dependent neuronal hyperactivation.
    Zott B; Simon MM; Hong W; Unger F; Chen-Engerer HJ; Frosch MP; Sakmann B; Walsh DM; Konnerth A
    Science; 2019 Aug; 365(6453):559-565. PubMed ID: 31395777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Verkhratsky A; Rodríguez JJ
    Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.
    Harris JA; Devidze N; Verret L; Ho K; Halabisky B; Thwin MT; Kim D; Hamto P; Lo I; Yu GQ; Palop JJ; Masliah E; Mucke L
    Neuron; 2010 Nov; 68(3):428-41. PubMed ID: 21040845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-derived amyloid-β protein induces Alzheimer's disease pathologies.
    Bu XL; Xiang Y; Jin WS; Wang J; Shen LL; Huang ZL; Zhang K; Liu YH; Zeng F; Liu JH; Sun HL; Zhuang ZQ; Chen SH; Yao XQ; Giunta B; Shan YC; Tan J; Chen XW; Dong ZF; Zhou HD; Zhou XF; Song W; Wang YJ
    Mol Psychiatry; 2018 Sep; 23(9):1948-1956. PubMed ID: 29086767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning impairment by minimal cortical injury in a mouse model of Alzheimer's disease.
    Zou J; Wang M; Uchiumi O; Shui Y; Ishigaki Y; Liu X; Tajima N; Akai T; Iizuka H; Kato N
    Brain Res; 2016 Apr; 1637():56-63. PubMed ID: 26876740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hippocalcin in mediating Aβ toxicity.
    Lim YA; Giese M; Shepherd C; Halliday G; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Götz J
    Biochim Biophys Acta; 2012 Aug; 1822(8):1247-57. PubMed ID: 22542901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
    Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
    Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease.
    Hamm V; Héraud C; Bott JB; Herbeaux K; Strittmatter C; Mathis C; Goutagny R
    Sci Adv; 2017 Feb; 3(2):e1601068. PubMed ID: 28275722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of γ-secretase activating protein expression in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2012 Apr; 38(2):132-41. PubMed ID: 21718343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
    Qin X; Wang Y; Paudel HK
    Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.